Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes
Clinical trial NCT07187752 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07187752
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2026-12-31
- Enrollment
- 1039
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.